Literature DB >> 12941343

The kinetics of binding to p38MAP kinase by analogues of BIRB 796.

John Regan1, Christopher A Pargellis, Pier F Cirillo, Thomas Gilmore, Eugene R Hickey, Gregory W Peet, Alfred Proto, Alan Swinamer, Neil Moss.   

Abstract

BIRB 796, a member of the N-pyrazole-N'-naphthly urea class of p38MAPK inhibitors, binds to the kinase with both slow association and dissociation rates. Prior to binding, the kinase undergoes a reorganization of the activation loop exposing a critical binding domain. We demonstrate that, independent of the loop movement, association rates are governed by low energy conformations of the inhibitor and polar functionality on the tolyl ring. As anticipated, the dissociation rates of the inhibitors from the kinase are slowed by lipophilic and hydrogen bond interactions. The value of structure-kinetic relationships (SKR) in drug design is discussed.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12941343     DOI: 10.1016/s0960-894x(03)00656-5

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  20 in total

1.  Strategies to design pyrazolyl urea derivatives for p38 kinase inhibition: a molecular modeling study.

Authors:  Ravindra G Kulkarni; Palukuri Srivani; Garlapati Achaiah; G Narahari Sastry
Journal:  J Comput Aided Mol Des       Date:  2007-01-04       Impact factor: 3.686

2.  Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.

Authors:  Wanli You; Chia-En A Chang
Journal:  J Chem Inf Model       Date:  2018-04-16       Impact factor: 4.956

3.  Fragment-based lead generation: identification of seed fragments by a highly efficient fragment screening technology.

Authors:  Lars Neumann; Allegra Ritscher; Gerhard Müller; Doris Hafenbradl
Journal:  J Comput Aided Mol Des       Date:  2009-06-17       Impact factor: 3.686

4.  Kinase inhibitors: an allosteric add-on.

Authors:  Zachariah H Foda; Markus A Seeliger
Journal:  Nat Chem Biol       Date:  2014-09-07       Impact factor: 15.040

5.  In situ kinase profiling reveals functionally relevant properties of native kinases.

Authors:  Matthew P Patricelli; Tyzoon K Nomanbhoy; Jiangyue Wu; Heidi Brown; David Zhou; Jianming Zhang; Subadhra Jagannathan; Arwin Aban; Eric Okerberg; Chris Herring; Brian Nordin; Helge Weissig; Qingkai Yang; Jiing-Dwan Lee; Nathanael S Gray; John W Kozarich
Journal:  Chem Biol       Date:  2011-06-24

Review 6.  "Go upstream, young man": lessons learned from the p38 saga.

Authors:  D Hammaker; G S Firestein
Journal:  Ann Rheum Dis       Date:  2010-01       Impact factor: 19.103

7.  Conformation-selective inhibitors reveal differences in the activation and phosphate-binding loops of the tyrosine kinases Abl and Src.

Authors:  Sanjay B Hari; B Gayani K Perera; Pratistha Ranjitkar; Markus A Seeliger; Dustin J Maly
Journal:  ACS Chem Biol       Date:  2013-10-29       Impact factor: 5.100

8.  Accurate calculation of mutational effects on the thermodynamics of inhibitor binding to p38α MAP kinase: a combined computational and experimental study.

Authors:  Shun Zhu; Sue M Travis; Adrian H Elcock
Journal:  J Chem Theory Comput       Date:  2013-07-09       Impact factor: 6.006

9.  The transition between active and inactive conformations of Abl kinase studied by rock climbing and Milestoning.

Authors:  Brajesh Narayan; Arman Fathizadeh; Clark Templeton; Peng He; Shima Arasteh; Ron Elber; Nicolae-Viorel Buchete; Ron M Levy
Journal:  Biochim Biophys Acta Gen Subj       Date:  2019-12-27       Impact factor: 3.770

10.  Structural characterization of proline-rich tyrosine kinase 2 (PYK2) reveals a unique (DFG-out) conformation and enables inhibitor design.

Authors:  Seungil Han; Anil Mistry; Jeanne S Chang; David Cunningham; Matt Griffor; Peter C Bonnette; Hong Wang; Boris A Chrunyk; Gary E Aspnes; Daniel P Walker; Arthur D Brosius; Leonard Buckbinder
Journal:  J Biol Chem       Date:  2009-02-25       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.